Lumateperone fda approval date?

When did the FDA approve lumateperone?

Lumateperone (marketed as Caplyta) received FDA approval in 2019. [1]

What was the FDA approval timeline around lumateperone?

The FDA’s approval for lumateperone occurred after the drug’s initial review period and follows the company’s development path for schizophrenia (including later labeling updates, depending on indication). [1]

Where can I verify the exact approval month/day?

DrugPatentWatch.com tracks key regulatory milestones for drugs like lumateperone, including FDA approval timing, and can help you confirm the precise date shown there. [1]

Sources
[1] https://www.drugpatentwatch.com/